For the approximately 15 million Americans that suffer from food allergies, good news is on the horizon: a lower-cost, generic version of EpiPen is to be released this week, and an even more affordable competitor will launch in 2017.

Mylan's jacked up EpiPen prices were a slap in the face to those who suffer from food allergies, but luckily they're finally realizing how unfair it is to charge $500+ for the lifesaving drug. While it'll still be more expensive than what EpiPen used to cost (it was once as low as $100 out of pocket), Coloradans will only be paying a more-reasonable $300 for a 2-pack of a generic EpiPen before insurance.

According to Mylan's website, the generic drug will be the same as the original EpiPen with the only difference being the label. Instead of having the EpiPen brand name, it is labeled as Mylan's Epinephrine Injection, USP Auto-Injector.

These lower-cost generic EpiPens are supposed to hit the shelves this week, and customers can also get a $25 coupon to be taken off out-of-pocket costs for each 2-pack of Mylan's authorized generic (good for up to 3 packs per prescription).

If $300 is still way too far out of your budget, there's still hope. In 2017, competitor drug company Kaleo will re-launch its own version of the drug called AUVI-Q, which is said to become available at an even lower price. AUVI-Q is literally the same thing (epinephrine injection, USP) as the EpiPen and generic EpiPen, but is distributed by an entirely different drug company.